David Szekeres | Executive Vice President, Chief Operating Officer |
Barry Quart | Chief Executive Officer and Chairman of the Board |
John Poyhonen | President and Chief Commercial Officer; |
Kimberly Manhard | Executive Vice President, Drug Development and Director |
Joshua Schimmer | Evercore ISI |
Brandon Folkes | Cantor Fitzgerald |
Boris Peaker | Cowen |
Serge Belanger | Needham & Company |
Kelly Shi | Jefferies |
Josh Schimmer | Evercore ISI |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2021 Earnings Conference.
As a reminder, this conference is being recorded.
Now I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed.